Do you want to read an article? Please log in or register.
Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension
Pulmonary FibrosisPulmonary Hypertension
RECOMMENDED
Related content
RECOMMENDED
Pulmonary Hypertension
Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
Respir Res.
Marra AM, Halank M, Benjamin N, Bossone E, Cittadini A, Eichstaedt CA, Egenlauf B, Harutyunova S, Fischer C, Gall H, Ghofrani HA, Hoeper MM, Lange TJ, Olsson KM, Klose H, Grünig E
doi: 10.1186/s12931-018-0957-y.
Pulmonary Hypertension
Gasometric gradients between blood obtained from the pulmonary artery wedge and pulmonary artery positions in pulmonary arterial hypertension
Respir Res.
Khirfan G, Ahmed MK, Faulx MD, Dakkak W, Dweik RA, Tonelli AR
doi: 10.1186/s12931-018-0969-7.
RECOMMENDED
Pulmonary Hypertension
Pregnancy-associated plasma protein A - a new indicator of pulmonary vascular remodeling in chronic thromboembolic pulmonary hypertension?
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res.
Kriechbaum SD, Rudolph F, Wiedenroth CB, Mielzarek L, Haas M, Guth S, Hamm CW, Mayer E, Liebetrau C, Keller T
doi: 10.1186/s12931-020-01472-3.
COMMENTED
Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial
Lancet Respir Med.
Raghu G, Pellegrini CA, Yow E, Flaherty KR, Meyer K, Noth I, Scholand MB, Cello J, Ho LA, Pipavath S, Lee JS, Lin J, Maloney J, Martinez FJ, Morrow E, Patti MG, Rogers S, Wolters PJ, Yates R, Anstrom KJ, Collard HR
doi: 10.1016/
RECOMMENDED
Pulmonary Hypertension
Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med.
Maron BA, Brittan EL, Hess E, Waldo SW, Barón AE, Huang S, Goldstein RH, Assad T, Wertheim BM, Alba GA, Leopold JA, Olschewski H, Galiè N, Simonneau G, Kovacs G, Tedford RJ, Humbert M, Choudhary G
doi: 10.1016/S2213-2600(20)30317-9.
Invasive haemodynamic evaluation of the pulmonary circulation in pulmonary hypertension
Swiss Med Wkly.
Pagnamenta A, Azzola A, Beghetti M, Lador F, On Behalf Of The Swiss Society Of Pulmonary Hypertension
doi: smw.2017.14445
RECOMMENDED
Pulmonary Hypertension
Risk Assessment in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Eur Respir J.
Humbert M, Farber HW, Ghofrani HA, Benza RL, Busse D, Meier C, Hoeper MM
doi: 10.1183/13993003.
RECOMMENDED
Pulmonary Fibrosis
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med.
Richeldi L, Fernández Pérez ER, Costabel U, Albera C, Lederer DJ, Flaherty KR, Ettinger N, Perez R, Scholand MB, Goldin J, Peony Yu KH, Neff T, Porter S, Zhong M, Gorina E, Kouchakji E, Raghu G
doi: 10.1016/S2213-2600(19)30262-0.
Pulmonary Hypertension
Targeting Jak-Stat Signaling in Experimental Pulmonary Hypertension
Am J Respir Cell Mol Biol.
Yerabolu D, Weiss A, Kojonazarov B, Boehm M, Schlueter BC, Ruppert C, Günther A, Jonigk D, Grimminger F, Ghofrani HA, Seeger W, Weissmann N, Schermuly RT
doi: 10.1165/rcmb.2019-0431OC.